Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Vitamin D in inflammatory diseases.
Significant increase in the prevalence of multiple sclerosis in iran in 2011.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007.
A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation.
Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Intention tremor and deficits of sensory feedback control in multiple sclerosis: a pilot study.
Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test.
Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy.
Multiple sclerosis: from molecules to treatment.
The role of the sema4D/CD72-dependent signal in the regulation of B-cell activity in multiple sclerosis.
Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Music mnemonics aid Verbal Memory and Induce Learning - Related Brain Plasticity in Multiple Sclerosis.
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.
Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier.
Pages
« first
‹ previous
…
286
287
288
289
290
291
292
293
294
…
next ›
last »